Skip to main content
. 2021 May 26;8:685362. doi: 10.3389/fmolb.2021.685362

FIGURE 2.

FIGURE 2

Taurine supplementation protected C2C12 myoblasts against cisplatin-induced cell viability decrease. (A) Representative morphological images of the three groups of C2C12 myoblasts (NOR, CIS, and TAU). Scale bar, 100 μm. (B) Percentage of cell viability measured by the MTS assay (n = 6). (C, D) Expression of caspase-3 and cleaved-caspase-3 in the three groups of C2C12 myoblasts (n = 8).